| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 216581-76-9 | 1,3-Adamantanediol monoacrylate | C13H18O3 |
| 216597-12-5 | Trimethoxysilane Terminated Polyether | (C3H6O)nC14H32N2O9Si2 |
| 216672-17-2 | 3-carboxy-2-oxo-2H-1-benzopyran-7-yl beta-D-Glucopyranosiduronic acid dipotassium salt | C16H12O11.2K |
| 216672-37-6 | 1-(Carboxymethyl)-6-methoxyquinolinium bromide | C12H12NO3.Br |
| 216699-35-3 | 5-Carboxy-X-rhodamine | C33H30N2O5 |
| 216699-36-4 | 6-Carboxy-X-rhodamine succinimidyl ester | C29H26ClN3O7 |
| 216699-86-4 | 2-Chloro-6,7-dimethoxyquinoxaline | C10H9ClN2O2 |
| 216755-56-5 | 3-Bromo-5-fluorobenzyl alcohol | C7H6BrFO |
| 216755-57-6 | 3-Bromo-5-fluorobenzyl bromide | C7H5Br2F |
| 216757-33-4 | N-Acetyl-L-isoleucyl-L-alpha-glutamyl-L-prolyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-alpha-asparagine | C32H41N5O11 |
| 216766-12-0 | 6-(Trifluoromethyl)pyridin-3-ol | C6H4F3NO |
| 216766-13-1 | 5-Methoxy-2-(trifluoromethyl)pyridine | C7H6F3NO |
| 216854-23-8 | (S)-3-N-Boc-aminopiperidine | C10H20N2O2 |
| 216854-24-9 | (R)-1-Benzyl-3-N-Boc-aminopiperidine | C17H26N2O2 |
| 216854-53-4 | 1-(2-Propenyl)-1,2-hydrazinedicarboxaldehyde | C5H8N2O2 |
| 216854-55-6 | Ethanethioic acid S-(1,2-diformyl-4-pyrazolidinyl) ester | C7H10N2O3S |
| 216854-76-1 | Dexamethasone Fluorescein | C45H45FN2O9S2 |
| 216869-17-9 | Levothyroxine Impurity 08 | C17H22FN3O4 |
| 216876-53-8 | alpha-[1-[(4-Chlorophenyl)amino]ethylidene]tetrahydro-2,5-dioxo-3-furanacetic acid ethyl ester | C16H16ClNO5 |
| 216959-91-0 | 4-(Pyrimidin-5-yl)benzoic acid | C11H8N2O2 |
| 216961-95-4 | [4-(3,5-Dimethyl-1H-pyrrol-2-yl-$greek954$N)-4-(3,5-dimethyl-2H-pyrrol-2-ylidene-$greek954$N)butanoato](difluoro)boron | C16H19BF2N2O2 |
| 216961-98-7 | 216961-98-7 | C20H22BF2N3O4 |
| 216964-01-1 | 2',7'-Dichlorodihydrofluorescein diacetate succinimidyl ester | C28H19Cl2NO9 |
| 216971-56-1 | 6-Chloro-1H-indol-3-yl beta-D-glucopyranosiduronic acid monosodium salt | C14H13ClNO7.Na |
| 216972-57-5 | 1-Chloro-3,5,7,9,11,13,15-heptacyclopentyloctasilsesquioxane | C35H63ClO12Si8 |
| 216974-75-3 | Bevacizumab | C6638H10160N1720O2108S44 |
| 216976-30-6 | 3-Fluoro-5-methylbenzonitrile | C8H6FN |
| 216976-31-7 | 3-Fluoro-5-methylphenol | C7H7FO |
| 216978-79-9 | 1,1,7,7-Tetramethyljulolidine-9-carboxaldehyde | C17H23NO |
| 216987-13-2 | 15-epi-Danshenol-A | C21H20O4 |
| 217073-76-2 | 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylic acid | C11H9FN2O2 |
| 217082-60-5 | Pyr-apelin-13 | C69H108N22O16S |
| 217087-09-7 | Esomeprazole magnesium trihydrate | 2(C17H18N3O3S).Mg.3(H2O) |
| 217087-10-0 | (S)-Omeprazole magnesium dihydrate | C34H36MgN6O6S2.2(H2O) |
| 217096-49-6 | Hugorosenone | C20H30O2 |
| 217099-43-9 | 2-Thiophenecarboxylic acid 2-(aminoiminomethyl)benzo[b]thien-6-yl ester | C14H10N2O2S2 |
| 217099-44-0 | BCX 1470 | C14H10N2O2S2.CH4O3S |
| 217171-01-2 | N-[[4-(1,1-Dimethylethyl)phenyl]methyl]-N-methyl-L-leucyl-N-(1,1-dimethylethyl)-O-(phenylmethyl)-L-tyrosinamide | C38H53N3O3 |
| 217175-10-5 | 1,1'-Bis[(11bR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]ferrocene | C50H32FeO4P2 |
| 217195-91-0 | Ethyl 2-hydroxy-2-(trifluoromethyl)-4-methyl-4-pentenoate | C9H13F3O3 |
| 217197-04-1 | 4-Nitro-2-(2,5,5-trimethyl-[1,3]dioxan-2-yl)benzoic acid | C14H17NO6 |
| 217197-05-2 | 4-Amino-2-[2,5,5-trimethyl-[1,3]dioxan-2-yl]benzoic acid | C14H19NO4 |
| 217300-17-9 | (Chloromethoxy)tris(1-methylethyl)silane | C10H23ClOSi |
| 217305-49-2 | Fluorescein diphosphate tetraammonium salt | C20H10O11P2.4(NH4) |
| 217313-79-6 | 4-(Aminomethyl)benzamidine dihydrochloride | C8H11N3.2(HCl) |
| 217314-47-1 | Methyl 3-amino-5-methoxybenzoate | C9H11NO3 |
| 217326-65-3 | 4-Bromobenzoxazole | C7H4BrNO |
| 217437-44-0 | 2-[(3,5-Dimethylpyrazolyl)carbonylamino]ethyl methacrylate | C12H17N3O3 |
| 217438-17-0 | N-Methyl-N-(2-methylphenyl)-3-nitro-4-(2-thiazolylsulfinyl)benzamide | C18H15N3O4S2 |
| 217448-86-7 | Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate | C11H9F2N3O2 |